SCHEMBL18090609

SCHEMBL18090609

COc1cc(F)c(N)c(C)c1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.38
ALDH1A1 P00352 3/20 0.38
CYP3A4 P08684 2/20 0.38
TUBB1 Q9H4B7 3/20 0.37
MAPT P10636 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HTR2A P28223 3/20 0.35
HTR2C P28335 3/20 0.35
HTR2B P41595 3/20 0.35
POLB P06746 2/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KDM4E B2RXH2 1/20 0.34
KDM1A O60341 2/20 0.33
NPC1 O15118 2/20 0.33
GAA P10253 1/20 0.33
MEN1 O00255 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27765600 0.87 ALDH1A1 (0.38) ACHEALDH1A1CYP3A4TUBB1MAPT
SCHEMBL30735735 0.83 ALDH1A1 (0.38) ACHEALDH1A1CYP3A4TUBB1MAPT
SCHEMBL21949630 0.77 MAPT (0.43) ALDH1A1CYP3A4TUBB1MAPTNPSR1
SCHEMBL3596792 0.77 POLB (0.42) ACHEALDH1A1CYP3A4TUBB1MAPT
SCHEMBL20149289 0.77 MAPT (0.39) ALDH1A1CYP3A4TUBB1MAPTNPSR1
SCHEMBL524923 0.74 MAPT (0.40) ACHEALDH1A1CYP3A4TUBB1MAPT
SCHEMBL27185258 0.74 MAPT (0.55) ACHEALDH1A1CYP3A4MAPTNPSR1
SCHEMBL16059989 0.74 ALDH1A1 (0.44) ACHEALDH1A1CYP3A4MAPTNPSR1
SCHEMBL25162229 0.73 ALDH1A1 (0.36) ALDH1A1CYP3A4MAPTPOLBTSHR
SCHEMBL9846429 0.73 ALDH1A1 (0.45) ACHEALDH1A1CYP3A4MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160257641-A1 NOVEL ALKYLENE DERIVATIVES SHIONOGI & CO., LTD. (JP) 2016-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160257641-A1 NOVEL ALKYLENE DERIVATIVES ACSS2, ACACB, ADCY2 ACHE 793/4885ALDH1A1 288/4885CYP3A4 548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.